BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 10, 2013
View Archived Issues
Investigators optogenetically delay seizures in animal models
Read More
Mouse model of congenital indifference to pain created
Read More
Copeptin is a marker of future stroke risk after transient ischemic attack
Read More
Diuretic and natriuretic effect of LCZ-696 in patients with hypertension
Read More
Researchers discover novel genetic biomarker for several human diseases
Read More
Expression of three genes predicts tolerance in renal transplant recipients
Read More
Millennium presents preclinical results for novel antibody-drug conjugate MLN-0264
Read More
Bio-Path opens enrollment in sixth cohort of phase I liposomal GRB2 trial
Read More
Second Genome and Janssen enter microbiome drug discovery agreement
Read More
Novavax develops novel coronavirus vaccine candidate
Read More
Oculus Innovative Sciences enters into agreement with Ruthigen
Read More
Esperion Therapeutics reports results from phase II study of ETC-1002
Read More
DMC recommends continuation of phase II ICT-107 trial
Read More
Eisai launches Belviq for chronic weight management
Read More
Researchers at Glenmark Pharmaceuticals patent new MPGES-1 inhibitors
Read More
Xention prepares new potassium channel blockers
Read More
Racotumomab, which improves lung cancer survival rate, soon to be available in Argentina
Read More
Gilead Sciences' receives priority review for sofosbuvir NDA
Read More
First compound from Eisai and Quintiles' anticancer collaboration demonstrates proof of concept
Read More
AstraZeneca signs definitive agreement to acquire Pearl Therapeutics
Read More
FDA approves Fluzone Quadrivalent influenza vaccine
Read More
EMA approves RoActemra for polyarticular juvenile idiopathic arthritis
Read More
Merck & Co. discloses novel GPR119 receptor agonists
Read More
Cephalon divulges new protein kinase inhibitors
Read More
Scientists at Astellas Pharma present novel DAAO inhibitors
Read More